News & Blog

November 14, 2024 | Press Release
Nobias Therapeutics Announces Strategic Focus and New Leadership
Read More
November 12, 2024 | Press Release
Aspen Neuroscience Chief Financial Officer Kameel Farag to Present at UBS Global Healthcare Conference
Read More
November 06, 2024 | In The News
In the News: Biotechnology’s Security Frontier: Navigating Innovation and Safeguards
Read More
November 01, 2024 | Blog Post
Q3 2024 MEC Newsletter
Read More
October 19, 2024 | Press Release
Study PRO-101: Experience implementing an ALS community advisory board in early phase drug development
Read More
October 08, 2024 | In The News
Endpoints News Honors Aspen Neuroscience Co-Founder Dr. Jeanne Loring in “20 Women Breaking New Ground”
Read More
October 08, 2024 | Press Release
Aspen Neuroscience Announces Collaboration and License Agreement with Cell X Technologies
Read More
September 30, 2024 | Press Release
Aspen Neuroscience Chief Financial Officer Kameel Farag to Present at Upcoming Investor Conferences
Read More
September 26, 2024 | Press Release
Aspen Neuroscience Announces Dosing Completion of First Cohort in ASPIRO Phase 1/2a Trial for Parkinson’s Disease
Read More
September 26, 2024 | Press Release
ProJenX and Unlearn Announce Partnership to Augment ALS Clinical Trial PRO-101 with Digital Twin Model
Read More